Ken Fisher’s Acadia Pharmaceuticals ACAD Stock Holding History

Ken Fisher’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.3M	Buy	732,872 +67,785	+10%	+$1.62M	0.01%	346
2025 Q4	$17.8M	Buy	665,087 +26,595	+4%	+$636K	0.01%	340
2025 Q3	$13.6M	Buy	638,492 +328,181	+106%	+$7.76M	﹤0.01%	373
2025 Q2	$6.69M	Sell	310,311 -44,710	-13%	-$831K	﹤0.01%	447
2025 Q1	$5.9M	Buy	355,021 +27,516	+8%	+$500K	﹤0.01%	471
2024 Q4	$6.01M	Buy	327,505 +132,906	+68%	+$2.15M	﹤0.01%	480
2024 Q3	$2.99M	Buy	194,599 +31,980	+20%	+$534K	﹤0.01%	536
2024 Q2	$2.64M	Buy	162,619 +9,689	+6%	+$156K	﹤0.01%	550
2024 Q1	$2.83M	Buy	152,930 +9,876	+7%	+$245K	﹤0.01%	556
2023 Q4	$4.48M	Buy	+143,054	New	+$3.42M	﹤0.01%	503

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Ken Fisher's ACAD Position: Q1 2026 in Review

Ken Fisher increased its Acadia Pharmaceuticals (ACAD) stake by 10% in Q1 2026, buying an estimated $1.62M and bringing the position to 732,872 shares worth $16.3M. The position accounts for 0.01% of the portfolio, ranked #346.

Ken Fisher first reported a position in ACAD in Q4 2023 and has held it in 10 quarters since. The position peaked at $17.8M in Q4 2025. 341 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

Ken Fisher held 732,872 shares of Acadia Pharmaceuticals worth $16.3M as of Q1 2026.
Ken Fisher bought 67,785 Acadia Pharmaceuticals shares in Q1 2026, an estimated $1.62M.
Acadia Pharmaceuticals made up 0.01% of Ken Fisher's portfolio in Q1 2026, its #346 holding.
Ken Fisher first reported a position in Acadia Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
Ken Fisher's Acadia Pharmaceuticals position peaked at $17.8M in Q4 2025.
341 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.